1 Study Coverage 1.1 Fibromyalgia Therapeutics Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Cymbalta (Duloxetine) 1.2.3 Savella (Milnacipran) 1.2.4 Lyrica (Pregabalin) 1.2.5 Pancuronium 1.2.6 Others 1.3 Market by Application 1.3.1 Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Fibromyalgia Therapeutics Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Fibromyalgia Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Fibromyalgia Therapeutics Drugs Sales by Region 2.4.1 Global Fibromyalgia Therapeutics Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Fibromyalgia Therapeutics Drugs by Region (2023-2028) 2.5 Global Fibromyalgia Therapeutics Drugs Revenue by Region 2.5.1 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2022) 2.5.2 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers 3.1.1 Global Top Fibromyalgia Therapeutics Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fibromyalgia Therapeutics Drugs in 2021 3.2 Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers 3.2.1 Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Fibromyalgia Therapeutics Drugs Revenue in 2021 3.3 Global Fibromyalgia Therapeutics Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Fibromyalgia Therapeutics Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Fibromyalgia Therapeutics Drugs Sales by Type 4.1.1 Global Fibromyalgia Therapeutics Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Fibromyalgia Therapeutics Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) 4.2 Global Fibromyalgia Therapeutics Drugs Revenue by Type 4.2.1 Global Fibromyalgia Therapeutics Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Fibromyalgia Therapeutics Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Fibromyalgia Therapeutics Drugs Price by Type 4.3.1 Global Fibromyalgia Therapeutics Drugs Price by Type (2017-2022) 4.3.2 Global Fibromyalgia Therapeutics Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Fibromyalgia Therapeutics Drugs Sales by Application 5.1.1 Global Fibromyalgia Therapeutics Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Fibromyalgia Therapeutics Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) 5.2 Global Fibromyalgia Therapeutics Drugs Revenue by Application 5.2.1 Global Fibromyalgia Therapeutics Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Fibromyalgia Therapeutics Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Fibromyalgia Therapeutics Drugs Price by Application 5.3.1 Global Fibromyalgia Therapeutics Drugs Price by Application (2017-2022) 5.3.2 Global Fibromyalgia Therapeutics Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Fibromyalgia Therapeutics Drugs Market Size by Type 6.1.1 North America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028) 6.1.2 North America Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2028) 6.2 North America Fibromyalgia Therapeutics Drugs Market Size by Application 6.2.1 North America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028) 6.2.2 North America Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2028) 6.3 North America Fibromyalgia Therapeutics Drugs Market Size by Country 6.3.1 North America Fibromyalgia Therapeutics Drugs Sales by Country (2017-2028) 6.3.2 North America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Fibromyalgia Therapeutics Drugs Market Size by Type 7.1.1 Europe Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028) 7.1.2 Europe Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2028) 7.2 Europe Fibromyalgia Therapeutics Drugs Market Size by Application 7.2.1 Europe Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028) 7.2.2 Europe Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2028) 7.3 Europe Fibromyalgia Therapeutics Drugs Market Size by Country 7.3.1 Europe Fibromyalgia Therapeutics Drugs Sales by Country (2017-2028) 7.3.2 Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Fibromyalgia Therapeutics Drugs Market Size by Type 8.1.1 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Fibromyalgia Therapeutics Drugs Market Size by Application 8.2.1 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Fibromyalgia Therapeutics Drugs Market Size by Region 8.3.1 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Fibromyalgia Therapeutics Drugs Market Size by Type 9.1.1 Latin America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028) 9.1.2 Latin America Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2028) 9.2 Latin America Fibromyalgia Therapeutics Drugs Market Size by Application 9.2.1 Latin America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028) 9.2.2 Latin America Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2028) 9.3 Latin America Fibromyalgia Therapeutics Drugs Market Size by Country 9.3.1 Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2017-2028) 9.3.2 Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Type 10.1.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Application 10.2.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Country 10.3.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Corporation Information 11.1.2 Pfizer Overview 11.1.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Pfizer Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Pfizer Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Corporation Information 11.2.2 Eli Lilly Overview 11.2.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Eli Lilly Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Eli Lilly Recent Developments 11.3 Actavis 11.3.1 Actavis Corporation Information 11.3.2 Actavis Overview 11.3.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Actavis Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Actavis Recent Developments 11.4 Merck Sharp and Dohme 11.4.1 Merck Sharp and Dohme Corporation Information 11.4.2 Merck Sharp and Dohme Overview 11.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Merck Sharp and Dohme Recent Developments 11.5 Daiichi Sankyo 11.5.1 Daiichi Sankyo Corporation Information 11.5.2 Daiichi Sankyo Overview 11.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Daiichi Sankyo Recent Developments 11.6 Innovative Med Concepts 11.6.1 Innovative Med Concepts Corporation Information 11.6.2 Innovative Med Concepts Overview 11.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Innovative Med Concepts Recent Developments 11.7 Meda 11.7.1 Meda Corporation Information 11.7.2 Meda Overview 11.7.3 Meda Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Meda Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Meda Recent Developments 11.8 Meiji Seika 11.8.1 Meiji Seika Corporation Information 11.8.2 Meiji Seika Overview 11.8.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Meiji Seika Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Meiji Seika Recent Developments 11.9 Switch Biotech 11.9.1 Switch Biotech Corporation Information 11.9.2 Switch Biotech Overview 11.9.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Switch Biotech Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Switch Biotech Recent Developments 11.10 Theravance 11.10.1 Theravance Corporation Information 11.10.2 Theravance Overview 11.10.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Theravance Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Theravance Recent Developments 11.11 Zynerba Pharmaceuticals 11.11.1 Zynerba Pharmaceuticals Corporation Information 11.11.2 Zynerba Pharmaceuticals Overview 11.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Zynerba Pharmaceuticals Recent Developments 11.12 Tonix Pharmaceuticals Holding Corp. (TNXP) 11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information 11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Overview 11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments 11.13 Daiichi Sankyo 11.13.1 Daiichi Sankyo Corporation Information 11.13.2 Daiichi Sankyo Overview 11.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Daiichi Sankyo Recent Developments 11.14 Forest Pharmaceuticals, Inc. 11.14.1 Forest Pharmaceuticals, Inc. Corporation Information 11.14.2 Forest Pharmaceuticals, Inc. Overview 11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Forest Pharmaceuticals, Inc. Recent Developments 11.15 Boehringer Ingelheim GmbH 11.15.1 Boehringer Ingelheim GmbH Corporation Information 11.15.2 Boehringer Ingelheim GmbH Overview 11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Boehringer Ingelheim GmbH Recent Developments 11.16 Pierre Fabre Mdicament 11.16.1 Pierre Fabre Mdicament Corporation Information 11.16.2 Pierre Fabre Mdicament Overview 11.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Pierre Fabre Mdicament Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Fibromyalgia Therapeutics Drugs Industry Chain Analysis 12.2 Fibromyalgia Therapeutics Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Fibromyalgia Therapeutics Drugs Production Mode & Process 12.4 Fibromyalgia Therapeutics Drugs Sales and Marketing 12.4.1 Fibromyalgia Therapeutics Drugs Sales Channels 12.4.2 Fibromyalgia Therapeutics Drugs Distributors 12.5 Fibromyalgia Therapeutics Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Fibromyalgia Therapeutics Drugs Industry Trends 13.2 Fibromyalgia Therapeutics Drugs Market Drivers 13.3 Fibromyalgia Therapeutics Drugs Market Challenges 13.4 Fibromyalgia Therapeutics Drugs Market Restraints 14 Key Findings in The Global Fibromyalgia Therapeutics Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Cymbalta (Duloxetine) Table 3. Major Manufacturers of Savella (Milnacipran) Table 4. Major Manufacturers of Lyrica (Pregabalin) Table 5. Major Manufacturers of Pancuronium Table 6. Major Manufacturers of Others Table 7. Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Fibromyalgia Therapeutics Drugs Sales by Region (2017-2022) & (Kg) Table 10. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2017-2022) Table 11. Global Fibromyalgia Therapeutics Drugs Sales by Region (2023-2028) & (Kg) Table 12. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2023-2028) Table 13. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million) Table 14. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2017-2022) Table 15. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million) Table 16. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2023-2028) Table 17. Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers (2017-2022) & (Kg) Table 18. Global Fibromyalgia Therapeutics Drugs Sales Share by Manufacturers (2017-2022) Table 19. Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 20. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers (2017-2022) Table 21. Fibromyalgia Therapeutics Drugs Price by Manufacturers (2017-2022) &(USD/g) Table 22. Global Fibromyalgia Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Fibromyalgia Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Therapeutics Drugs as of 2021) Table 24. Fibromyalgia Therapeutics Drugs Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Fibromyalgia Therapeutics Drugs Product Offered Table 26. Date of Manufacturers Enter into Fibromyalgia Therapeutics Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg) Table 29. Global Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg) Table 30. Global Fibromyalgia Therapeutics Drugs Sales Share by Type (2017-2022) Table 31. Global Fibromyalgia Therapeutics Drugs Sales Share by Type (2023-2028) Table 32. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million) Table 33. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million) Table 34. Global Fibromyalgia Therapeutics Drugs Revenue Share by Type (2017-2022) Table 35. Global Fibromyalgia Therapeutics Drugs Revenue Share by Type (2023-2028) Table 36. Fibromyalgia Therapeutics Drugs Price by Type (2017-2022) & (USD/g) Table 37. Global Fibromyalgia Therapeutics Drugs Price Forecast by Type (2023-2028) & (USD/g) Table 38. Global Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg) Table 39. Global Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg) Table 40. Global Fibromyalgia Therapeutics Drugs Sales Share by Application (2017-2022) Table 41. Global Fibromyalgia Therapeutics Drugs Sales Share by Application (2023-2028) Table 42. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million) Table 43. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million) Table 44. Global Fibromyalgia Therapeutics Drugs Revenue Share by Application (2017-2022) Table 45. Global Fibromyalgia Therapeutics Drugs Revenue Share by Application (2023-2028) Table 46. Fibromyalgia Therapeutics Drugs Price by Application (2017-2022) & (USD/g) Table 47. Global Fibromyalgia Therapeutics Drugs Price Forecast by Application (2023-2028) & (USD/g) Table 48. North America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg) Table 49. North America Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg) Table 50. North America Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million) Table 51. North America Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million) Table 52. North America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg) Table 53. North America Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg) Table 54. North America Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million) Table 55. North America Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million) Table 56. North America Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg) Table 57. North America Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg) Table 58. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million) Table 59. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million) Table 60. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg) Table 61. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg) Table 62. Europe Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million) Table 63. Europe Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million) Table 64. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg) Table 65. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg) Table 66. Europe Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million) Table 67. Europe Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million) Table 68. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg) Table 69. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg) Table 70. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million) Table 71. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million) Table 72. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg) Table 73. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg) Table 74. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million) Table 75. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million) Table 76. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg) Table 77. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg) Table 78. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million) Table 79. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million) Table 80. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2017-2022) & (Kg) Table 81. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2023-2028) & (Kg) Table 82. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million) Table 83. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million) Table 84. Latin America Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg) Table 85. Latin America Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg) Table 86. Latin America Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million) Table 87. Latin America Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million) Table 88. Latin America Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg) Table 89. Latin America Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg) Table 90. Latin America Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million) Table 91. Latin America Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million) Table 92. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg) Table 93. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg) Table 94. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million) Table 95. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million) Table 96. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Type (2017-2022) & (Kg) Table 97. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Type (2023-2028) & (Kg) Table 98. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million) Table 99. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million) Table 100. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Application (2017-2022) & (Kg) Table 101. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Application (2023-2028) & (Kg) Table 102. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million) Table 103. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million) Table 104. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2017-2022) & (Kg) Table 105. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2023-2028) & (Kg) Table 106. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million) Table 107. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million) Table 108. Pfizer Corporation Information Table 109. Pfizer Description and Major Businesses Table 110. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 111. Pfizer Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 112. Pfizer Recent Developments Table 113. Eli Lilly Corporation Information Table 114. Eli Lilly Description and Major Businesses Table 115. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 116. Eli Lilly Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 117. Eli Lilly Recent Developments Table 118. Actavis Corporation Information Table 119. Actavis Description and Major Businesses Table 120. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 121. Actavis Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Actavis Recent Developments Table 123. Merck Sharp and Dohme Corporation Information Table 124. Merck Sharp and Dohme Description and Major Businesses Table 125. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 126. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 127. Merck Sharp and Dohme Recent Developments Table 128. Daiichi Sankyo Corporation Information Table 129. Daiichi Sankyo Description and Major Businesses Table 130. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 131. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 132. Daiichi Sankyo Recent Developments Table 133. Innovative Med Concepts Corporation Information Table 134. Innovative Med Concepts Description and Major Businesses Table 135. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 136. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 137. Innovative Med Concepts Recent Developments Table 138. Meda Corporation Information Table 139. Meda Description and Major Businesses Table 140. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 141. Meda Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 142. Meda Recent Developments Table 143. Meiji Seika Corporation Information Table 144. Meiji Seika Description and Major Businesses Table 145. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 146. Meiji Seika Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 147. Meiji Seika Recent Developments Table 148. Switch Biotech Corporation Information Table 149. Switch Biotech Description and Major Businesses Table 150. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 151. Switch Biotech Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 152. Switch Biotech Recent Developments Table 153. Theravance Corporation Information Table 154. Theravance Description and Major Businesses Table 155. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 156. Theravance Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 157. Theravance Recent Developments Table 158. Zynerba Pharmaceuticals Corporation Information Table 159. Zynerba Pharmaceuticals Description and Major Businesses Table 160. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 161. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 162. Zynerba Pharmaceuticals Recent Developments Table 163. Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information Table 164. Tonix Pharmaceuticals Holding Corp. (TNXP) Description and Major Businesses Table 165. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 166. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 167. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments Table 168. Daiichi Sankyo Corporation Information Table 169. Daiichi Sankyo Description and Major Businesses Table 170. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 171. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 172. Daiichi Sankyo Recent Developments Table 173. Forest Pharmaceuticals, Inc. Corporation Information Table 174. Forest Pharmaceuticals, Inc. Description and Major Businesses Table 175. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 176. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 177. Forest Pharmaceuticals, Inc. Recent Developments Table 178. Boehringer Ingelheim GmbH Corporation Information Table 179. Boehringer Ingelheim GmbH Description and Major Businesses Table 180. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 181. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 182. Boehringer Ingelheim GmbH Recent Developments Table 183. Pierre Fabre Mdicament Corporation Information Table 184. Pierre Fabre Mdicament Description and Major Businesses Table 185. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 186. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 187. Pierre Fabre Mdicament Recent Developments Table 188. Key Raw Materials Lists Table 189. Raw Materials Key Suppliers Lists Table 190. Fibromyalgia Therapeutics Drugs Distributors List Table 191. Fibromyalgia Therapeutics Drugs Customers List Table 192. Fibromyalgia Therapeutics Drugs Market Trends Table 193. Fibromyalgia Therapeutics Drugs Market Drivers Table 194. Fibromyalgia Therapeutics Drugs Market Challenges Table 195. Fibromyalgia Therapeutics Drugs Market Restraints Table 196. Research Programs/Design for This Report Table 197. Key Data Information from Secondary Sources Table 198. Key Data Information from Primary Sources List of Figures Figure 1. Fibromyalgia Therapeutics Drugs Product Picture Figure 3. Global Fibromyalgia Therapeutics Drugs Market Share by Type in 2021 & 2028 Figure 3. Cymbalta (Duloxetine) Product Picture Figure 4. Savella (Milnacipran) Product Picture Figure 5. Lyrica (Pregabalin) Product Picture Figure 6. Pancuronium Product Picture Figure 7. Others Product Picture Figure 8. Global Fibromyalgia Therapeutics Drugs Market Share by Application in 2021 & 2028 Figure 9. Hospital Figure 10. Clinic Figure 11. Others Figure 12. Fibromyalgia Therapeutics Drugs Report Years Considered Figure 13. Global Fibromyalgia Therapeutics Drugs Sales 2017-2028 (Kg) Figure 14. Global Fibromyalgia Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Fibromyalgia Therapeutics Drugs Revenue 2017-2028 (US$ Million) Figure 16. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 17. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2017-2022) Figure 18. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2023-2028) Figure 19. North America Fibromyalgia Therapeutics Drugs Sales YoY (2017-2028) & (Kg) Figure 20. North America Fibromyalgia Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 21. Europe Fibromyalgia Therapeutics Drugs Sales YoY (2017-2028) & (Kg) Figure 22. Europe Fibromyalgia Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 23. Asia-Pacific Fibromyalgia Therapeutics Drugs Sales YoY (2017-2028) & (Kg) Figure 24. Asia-Pacific Fibromyalgia Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 25. Latin America Fibromyalgia Therapeutics Drugs Sales YoY (2017-2028) & (Kg) Figure 26. Latin America Fibromyalgia Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 27. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales YoY (2017-2028) & (Kg) Figure 28. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 29. The Fibromyalgia Therapeutics Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 30. The Top 5 and 10 Largest Manufacturers of Fibromyalgia Therapeutics Drugs in the World: Market Share by Fibromyalgia Therapeutics Drugs Revenue in 2021 Figure 31. Global Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 32. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) Figure 33. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) Figure 34. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) Figure 35. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) Figure 36. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) Figure 37. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) Figure 38. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) Figure 39. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) Figure 40. North America Fibromyalgia Therapeutics Drugs Sales Share by Country (2017-2028) Figure 41. North America Fibromyalgia Therapeutics Drugs Revenue Share by Country (2017-2028) Figure 42. U.S. Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 43. Canada Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 44. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) Figure 45. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) Figure 46. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) Figure 47. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) Figure 48. Europe Fibromyalgia Therapeutics Drugs Sales Share by Country (2017-2028) Figure 49. Europe Fibromyalgia Therapeutics Drugs Revenue Share by Country (2017-2028) Figure 50. Germany Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 51. France Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 52. U.K. Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 53. Italy Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 54. Russia Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 55. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) Figure 56. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) Figure 57. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) Figure 58. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) Figure 59. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Share by Region (2017-2028) Figure 60. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Share by Region (2017-2028) Figure 61. China Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 62. Japan Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 63. South Korea Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 64. India Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 65. Australia Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 66. Taiwan Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 67. Indonesia Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 68. Thailand Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 69. Malaysia Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 70. Philippines Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 71. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) Figure 72. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) Figure 73. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) Figure 74. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) Figure 75. Latin America Fibromyalgia Therapeutics Drugs Sales Share by Country (2017-2028) Figure 76. Latin America Fibromyalgia Therapeutics Drugs Revenue Share by Country (2017-2028) Figure 77. Mexico Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 78. Brazil Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 79. Argentina Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 80. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2017-2028) Figure 81. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2017-2028) Figure 82. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2017-2028) Figure 83. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2017-2028) Figure 84. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Share by Country (2017-2028) Figure 85. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Share by Country (2017-2028) Figure 86. Turkey Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 87. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 88. UAE Fibromyalgia Therapeutics Drugs Revenue (2017-2028) & (US$ Million) Figure 89. Fibromyalgia Therapeutics Drugs Value Chain Figure 90. Fibromyalgia Therapeutics Drugs Production Process Figure 91. Channels of Distribution Figure 92. Distributors Profiles Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

Pfizer Eli Lilly Actavis Merck Sharp and Dohme Daiichi Sankyo Innovative Med Concepts Meda Meiji Seika Switch Biotech Theravance Zynerba Pharmaceuticals Tonix Pharmaceuticals Holding Corp. (TNXP) Daiichi Sankyo Forest Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Pierre Fabre Mdicament